483
Lifecycle Biotechnologies, LPFDA 483 - Lifecycle Biotechnologies, LP - January 24, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Record Details
Lifecycle Biotechnologies, LP, a drug component manufacturer in Loveland, CO, was inspected by the FDA from January 24-28, 2022. The inspection revealed significant deficiencies in manufacturing controls, facility maintenance, and quality unit oversight. Key issues included inadequate yield determination, poor facility repair, and failures in production record review and training documentation.
Open in Dashboard
ID · fb675c25-f15b-42e8-b987-9a8da125cd8d